Michelle Glass
Affiliations: | Pharmacology | University of Auckland, Auckland, Auckland, New Zealand |
Google:
"Michelle Glass"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Green HM, Manning JJ, Greig IR, et al. (2024) Positive allosteric modulation of the cannabinoid CB receptor potentiates endocannabinoid signalling and changes ERK1/2 phosphorylation kinetics. British Journal of Pharmacology |
| Manning JJ, Finlay DB, Glass M. (2024) GPCR kinase subtype requirements for arrestin-2 and -3 translocation to the cannabinoid CB receptor and the consequences on G protein signalling. Biochemical Pharmacology. 224: 116190 |
| Patel M, Zheng X, Akinfiresoye LR, et al. (2024) Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists. European Journal of Pharmacology. 176549 |
| Green HM, Fellner DMJ, Finlay DB, et al. (2024) Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis Studies. Pharmaceuticals (Basel, Switzerland). 17 |
| Green HM, Yang L, Zhu X, et al. (2024) Insight into the mechanism of action of ORG27569 at the cannabinoid type one receptor utilising a unified mathematical model. Naunyn-Schmiedeberg's Archives of Pharmacology |
| Yang L, Finlay DB, Green HM, et al. (2023) A quantitative pharmacology model for cannabinoid receptor type 1 (CB ) mediated by Gi/Gs protein competition. British Journal of Pharmacology |
| Yang L, Zhu X, Finlay DB, et al. (2023) A kinetic model for positive allosteric modulator (PAM)-antagonists for the type 1 cannabinoid receptor (CB ). British Journal of Pharmacology |
| Finlay DB, Mackie W, Webb HDJ, et al. (2023) The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolism. Pharmacology, Biochemistry, and Behavior. 223: 173530 |
| Webb HDJ, Finlay DB, Chen S, et al. (2022) Characterisation of AMB-FUBINACA metabolism and CB-mediated activity of its acid metabolite. Forensic Toxicology. 41: 114-125 |
| Manning JJ, Rawcliffe G, Finlay DB, et al. (2022) Cannabinoid type-1 receptor arrestin subtype-selectivity and phosphorylation dependence. British Journal of Pharmacology |